Coridea, LLC
New York, NY · Medtech · Private
Endobronchial radio-frequency ablation (RFA) catheter system for percutaneous thermal ablation of peripheral lung tumors via bronchoscope
coridea.com →- Grants
- $18M
- 27 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 1 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Painless Defibrillation | $505,020 | |
| Federal grant | Department of Health and Human Services · Phase II · Painless Defibrillation | $492,501 | |
| Federal grant | Department of Health and Human Services · Phase II · Prevention of Syncope with GSN Stimulation | $740,435 | |
| Federal grant | Department of Health and Human Services · Phase II · Prevention of Syncope with GSN Stimulation | $726,029 | |
| Federal grant | Department of Health and Human Services · Phase II · Minimally Invasive Cardiac Sympathetic Denervation for Malignant Ventricular Arrhythmia | $224,221 | |
| Federal grant | Department of Health and Human Services · Phase I · Automatic Phrenic Nerve Stimulation to Rescue Opioid Induced Respiratory Depression | $224,959 | |
| Federal grant | Department of Health and Human Services · Phase II · Minimally Invasive Cardiac Sympathetic Denervation for Malignant Ventricular Arrhythmia | $755,923 | |
| Federal grant | Department of Health and Human Services · Phase II · Minimally Invasive Cardiac Sympathetic Denervation for Malignant Ventricular Arrhythmia | $1,498,305 | |
| Federal grant | Department of Health and Human Services · Phase II · Painless Defibrillation | $994,306 | |
| Federal grant | Department of Health and Human Services · Phase II · Minimally Invasive Cardiac Sympathetic Denervation for Malignant Ventricular Arrhythmia | $742,382 | |
| Federal grant | Department of Health and Human Services · Phase I · Minimally Invasive Cardio-Pulmonary Plexus Block for the Treatment of Pulmonary Hypertension | $224,791 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation | $224,929 | |
| Federal grant | Department of Health and Human Services · Phase II · Painless Defibrillation | $993,536 | |
| Federal grant | Department of Health and Human Services · Phase II · Endobronchial Supervalve for the Treatment of Emphysema | $246,415 | |
| Federal grant | Department of Health and Human Services · Phase II · Painless Defibrillation | $982,600 | |
| Federal grant | Department of Health and Human Services · Phase II · Endobronchial Supervalve for the Treatment of Emphysema | $1,919,606 | |
| Federal grant | Department of Health and Human Services · Phase I · On Demand Electrostimulation | $223,921 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation | $1,567,912 | |
| Federal grant | Department of Health and Human Services · Phase II · Endobronchial Supervalve for the Treatment of Emphysema | $988,194 | |
| Federal grant | Department of Health and Human Services · Phase I · Coridea NIH I-Corps Program | $54,863 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation | $784,016 | |
| Federal grant | Department of Health and Human Services · Phase II · Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy | $784,548 | |
| Federal grant | Department of Health and Human Services · Phase II · Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy | $122,700 | |
| Federal grant | Department of Health and Human Services · Phase II · Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy | $941,991 | |
| Federal grant | Department of Health and Human Services · Phase II · Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy | $122,700 | |
| Federal grant | Department of Health and Human Services · Phase I · Stellate Ganglion Stimulation in Septic Shock to Improve Hemodynamics and Vasopressor Requirements | $274,839 | |
| Federal grant | Department of Health and Human Services · Phase II · ENT-based Approach to Cervical Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea | $982,086 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1983 | Spine Align LLC | — | — |
| 1984 | VERSAGO VASCULAR ACCESS, INC. | — | $440K |
| 1985 | TRANSONIC SYSTEMS, INC. | — | — |
| 1986 | Coridea, LLC | — | — |
| 1987 | CONFORM MEDICAL INC | — | — |
| 1988 | AMYGO SOLUTIONS LLC | — | — |
| 1989 | Theator Inc. | — | $38M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method And Apparatus To Treat Cardiopulmonary Diseasegranted
- Devices And Methods For Treating Lung Tumorsapplication
- Devices And Methods For Treating Lung Tumorsapplication
- Devices And Methods For Treating Lung Tumorsapplication
- Devices and Methods for Treating Lung Tumorsapplication
- Apparatus To Treat Cardiopulmonary Diseaseapplication
- Methods And Devices For The Treatment Of Pulmonary Disordersapplication
- Methods And Devices For Treating A Hyper-inflated Lungapplication
- Methods And Devices For The Treatment Of Pulmonary Disorders With Implantable Valvesapplication
- Methods And Devices For Treating A Hyper-inflated Lungapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.